Chronic inhibition of sEH substantially attenuated lung congestion and albuminuria parallel to preserved cardiac function and structure, acknowledging sEH as a therapeutic target for the treatment of HF associated with chronic kidney disease [210,211]. The gene discussed is EPHX2; the disease is chronic kidney disease.